Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE44.4100
- TODAY'S CHANGE (%)-0.9600 (-2.1159%)
- Bid / Lots42.3100/ 1
- Ask / Lots46.5000/ 1
- Open / Previous Close45.6900 / 45.3700
- Day Range
- 52 Week Range
- Volume1,038,397
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2661 | 45.945 |
| 09:34 ET | 100 | 45.56 |
| 09:36 ET | 100 | 45.975 |
| 09:39 ET | 100 | 46.09 |
| 09:41 ET | 400 | 46.08 |
| 09:43 ET | 350 | 46.24 |
| 09:45 ET | 500 | 46.13 |
| 09:48 ET | 803 | 46.09 |
| 09:50 ET | 2664 | 46.43 |
| 09:52 ET | 1704 | 46.775 |
| 09:54 ET | 400 | 46.755 |
| 09:56 ET | 1909 | 46.8 |
| 09:57 ET | 1100 | 46.6617 |
| 09:59 ET | 300 | 46.62 |
| 10:01 ET | 1096 | 46.61 |
| 10:03 ET | 962 | 46.51 |
| 10:06 ET | 604 | 46.48 |
| 10:08 ET | 8449 | 46.71 |
| 10:10 ET | 8056 | 46.6 |
| 10:12 ET | 1904 | 46.545 |
| 10:14 ET | 5861 | 46.45 |
| 10:15 ET | 700 | 46.43 |
| 10:17 ET | 536 | 46.445 |
| 10:19 ET | 1467 | 46.415 |
| 10:21 ET | 6515 | 46.44 |
| 10:24 ET | 2200 | 46.61 |
| 10:26 ET | 1371 | 46.31 |
| 10:28 ET | 2172 | 46.16 |
| 10:30 ET | 704 | 46.04 |
| 10:32 ET | 500 | 45.89 |
| 10:33 ET | 20547 | 45.985 |
| 10:35 ET | 2713 | 45.89 |
| 10:37 ET | 200 | 45.91 |
| 10:39 ET | 1057 | 46.08 |
| 10:42 ET | 2859 | 45.975 |
| 10:44 ET | 2444 | 46.03 |
| 10:46 ET | 5100 | 45.82 |
| 10:48 ET | 14406 | 45.64 |
| 10:50 ET | 802 | 45.65 |
| 10:51 ET | 500 | 45.65 |
| 10:53 ET | 2613 | 45.815 |
| 10:55 ET | 300 | 45.7 |
| 10:57 ET | 300 | 45.86 |
| 11:00 ET | 300 | 45.825 |
| 11:02 ET | 1292 | 45.82 |
| 11:04 ET | 966 | 45.65 |
| 11:06 ET | 3081 | 45.6532 |
| 11:09 ET | 200 | 45.71 |
| 11:11 ET | 2223 | 45.715 |
| 11:13 ET | 800 | 45.79 |
| 11:15 ET | 9518 | 45.68 |
| 11:18 ET | 5412 | 45.5291 |
| 11:20 ET | 900 | 45.535 |
| 11:22 ET | 2080 | 45.465 |
| 11:24 ET | 1400 | 45.55 |
| 11:26 ET | 316 | 45.575 |
| 11:27 ET | 1100 | 45.57 |
| 11:31 ET | 1390 | 45.52 |
| 11:36 ET | 100 | 45.435 |
| 11:38 ET | 200 | 45.37 |
| 11:40 ET | 879 | 45.385 |
| 11:42 ET | 200 | 45.42 |
| 11:47 ET | 400 | 45.405 |
| 11:49 ET | 17374 | 45.495 |
| 11:51 ET | 1178 | 45.46 |
| 11:54 ET | 1100 | 45.52 |
| 11:56 ET | 907 | 45.56 |
| 11:58 ET | 1406 | 45.57 |
| 12:00 ET | 502 | 45.515 |
| 12:02 ET | 856 | 45.415 |
| 12:05 ET | 413 | 45.33 |
| 12:07 ET | 400 | 45.34 |
| 12:09 ET | 716 | 45.35 |
| 12:12 ET | 1132 | 45.225 |
| 12:14 ET | 1654 | 45.215 |
| 12:16 ET | 4214 | 45.1 |
| 12:18 ET | 1000 | 45.15 |
| 12:20 ET | 3972 | 45.03 |
| 12:21 ET | 3604 | 45.15 |
| 12:23 ET | 200 | 45.06 |
| 12:25 ET | 3494 | 45.09 |
| 12:30 ET | 500 | 45 |
| 12:32 ET | 200 | 45.04 |
| 12:34 ET | 467 | 45.03 |
| 12:36 ET | 200 | 45.03 |
| 12:38 ET | 1823 | 44.99 |
| 12:39 ET | 867 | 44.96 |
| 12:41 ET | 218 | 44.96 |
| 12:43 ET | 5000 | 45.08 |
| 12:45 ET | 200 | 45.07 |
| 12:48 ET | 1279 | 45.14 |
| 12:50 ET | 800 | 45.08 |
| 12:52 ET | 1102 | 45.04 |
| 12:54 ET | 700 | 45.13 |
| 12:56 ET | 350 | 45.12 |
| 12:57 ET | 100 | 45.13 |
| 01:01 ET | 1100 | 45.07 |
| 01:03 ET | 1321 | 45.24 |
| 01:06 ET | 1392 | 45.215 |
| 01:08 ET | 298 | 45.19 |
| 01:10 ET | 872 | 45.145 |
| 01:12 ET | 4252 | 45.07 |
| 01:14 ET | 200 | 45.03 |
| 01:15 ET | 1150 | 45.02 |
| 01:17 ET | 3998 | 44.97 |
| 01:19 ET | 100 | 44.98 |
| 01:21 ET | 1215 | 45.01 |
| 01:24 ET | 2000 | 45.055 |
| 01:26 ET | 1000 | 45.02 |
| 01:28 ET | 800 | 45.03 |
| 01:30 ET | 2921 | 45.115 |
| 01:32 ET | 2298 | 45.075 |
| 01:35 ET | 1800 | 45.09 |
| 01:37 ET | 1796 | 44.96 |
| 01:39 ET | 1852 | 44.935 |
| 01:42 ET | 1235 | 44.88 |
| 01:44 ET | 1740 | 44.94 |
| 01:46 ET | 400 | 44.95 |
| 01:48 ET | 600 | 44.99 |
| 01:50 ET | 200 | 45.02 |
| 01:51 ET | 518 | 44.98 |
| 01:53 ET | 1707 | 44.895 |
| 01:55 ET | 3121 | 44.87 |
| 01:57 ET | 1315 | 44.8725 |
| 02:00 ET | 1999 | 44.77 |
| 02:02 ET | 200 | 44.78 |
| 02:04 ET | 800 | 44.78 |
| 02:06 ET | 1901 | 44.805 |
| 02:08 ET | 1816 | 44.84 |
| 02:09 ET | 300 | 44.9 |
| 02:11 ET | 1100 | 44.79 |
| 02:13 ET | 1717 | 44.85 |
| 02:15 ET | 2820 | 44.76 |
| 02:18 ET | 500 | 44.82 |
| 02:20 ET | 1587 | 44.8599 |
| 02:22 ET | 5363 | 44.755 |
| 02:24 ET | 100 | 44.73 |
| 02:27 ET | 3769 | 44.79 |
| 02:29 ET | 900 | 44.8 |
| 02:31 ET | 800 | 44.79 |
| 02:33 ET | 200 | 44.82 |
| 02:36 ET | 1875 | 44.83 |
| 02:38 ET | 3852 | 44.72 |
| 02:40 ET | 1141 | 44.59 |
| 02:42 ET | 1660 | 44.6 |
| 02:44 ET | 919 | 44.62 |
| 02:45 ET | 2078 | 44.67 |
| 02:47 ET | 1189 | 44.62 |
| 02:49 ET | 1300 | 44.54 |
| 02:51 ET | 2385 | 44.51 |
| 02:54 ET | 1300 | 44.54 |
| 02:56 ET | 3246 | 44.56 |
| 02:58 ET | 510 | 44.61 |
| 03:00 ET | 1461 | 44.595 |
| 03:02 ET | 3165 | 44.65 |
| 03:03 ET | 3246 | 44.38 |
| 03:05 ET | 2323 | 44.42 |
| 03:07 ET | 2500 | 44.46 |
| 03:09 ET | 1300 | 44.44 |
| 03:12 ET | 1240 | 44.39 |
| 03:14 ET | 2500 | 44.44 |
| 03:16 ET | 800 | 44.43 |
| 03:18 ET | 1381 | 44.46 |
| 03:20 ET | 3354 | 44.44 |
| 03:21 ET | 2100 | 44.41 |
| 03:23 ET | 1638 | 44.39 |
| 03:25 ET | 2936 | 44.445 |
| 03:27 ET | 1400 | 44.48 |
| 03:30 ET | 1703 | 44.41 |
| 03:32 ET | 1478 | 44.445 |
| 03:34 ET | 6657 | 44.24 |
| 03:36 ET | 6441 | 44.2 |
| 03:38 ET | 2300 | 44.285 |
| 03:39 ET | 3835 | 44.23 |
| 03:41 ET | 6519 | 44.18 |
| 03:43 ET | 15086 | 44.2833 |
| 03:45 ET | 3019 | 44.29 |
| 03:48 ET | 2344 | 44.26 |
| 03:50 ET | 34093 | 44.52 |
| 03:52 ET | 15666 | 44.44 |
| 03:54 ET | 8030 | 44.39 |
| 03:56 ET | 16669 | 44.51 |
| 03:57 ET | 19566 | 44.41 |
| 03:59 ET | 33858 | 44.41 |
May 30, 2024
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs, from 4:05PM ET on Thursday May 30, 2024 by Dow Jones
4:05PM ET on Thursday May 30, 2024 by Dow JonesPress Release: Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs, from 4:05PM ET on Thursday May 30, 2024 by Dow Jones
4:05PM ET on Thursday May 30, 2024 by Dow Jones
May 23, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Outperform by Baird, from 12:48PM ET on Thursday May 23, 2024 by Dow Jones
12:48PM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Overweight by Morgan Stanley, from 11:33AM ET on Thursday May 23, 2024 by Dow Jones
11:33AM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:25AM ET on Thursday May 23, 2024 by Dow Jones
7:25AM ET on Thursday May 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -11.8x | --- |
Immunovant Inc | 3.7B | -13.5x | --- |
Merus NV | 3.6B | -19.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Dyne Therapeutics Inc | 3.1B | -8.0x | --- |
Biohaven Ltd | 3.1B | -5.1x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.8x |
Price/Sales (TTM) | 1,774.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
